Ozempic and other weight loss drugs are coming for the alcohol and tobacco industries next

Posted
It’s not only food CEOs who need to worry about their bottom lines thanks to in-demand weight loss drugs like Ozempic. Big Tobacco and Alcohol have reason to fret, too.Read more...

Continue reading at Quartz »

alcohol, morgan stanley, anti obesity medication, tirzepatide, health medical pharma, glp 1 receptor agonist, semaglutide, glucagon like peptide 1, peptide therapeutics, peptide hormones, glp 1, anti diabetic drugs, glp1 poly agonist peptides, draftfood noise, drinking culture